Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice. Yang Y, Jiang H, Tang Z, Pan H, et al. J Autoimmun 2024;146:103237.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang Y, Jiang H, Tang Z, Pan H, et al. Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice. J Autoimmun 2024;146:103237.
PMID: 38749076